Silver Book Fact

A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.

Papadimitropoulos, Emmanuel, George Wells, Beverley Shea, William Gillespie, Bruce Weaver, Nicole Zytaruk, Ann Cranney, Jonathan D. Adachi, Peter Tugwell, Robert Josse, Carol Greenwood, and Gordon Guyatt. VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women. Endocr Rev. 2002; 23(4): 560-9. http://edrv.endojournals.org/cgi/content/full/23/4/560

Reference

Title
VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women
Publication
Endocr Rev
Publication Date
2002
Authors
Papadimitropoulos, Emmanuel, George Wells, Beverley Shea, William Gillespie, Bruce Weaver, Nicole Zytaruk, Ann Cranney, Jonathan D. Adachi, Peter Tugwell, Robert Josse, Carol Greenwood, and Gordon Guyatt
Volume & Issue
Volume 23, Issue 4
Pages
560-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A meta-analysis of clinical trials found that calcium supplements reduced the risk of vertebral fractures by around 23%.  
  • Teriparatide, or human recombinant PTH, has been shown to decrease vertebral fractures by 65% to 69%, and non-vertebral fragility fractures by around 53%.  
  • Risedronate, a bisphosphonate, has been shown to reduce vertebral fractures by around 41%, hip fractures by 30%, and non-vertebral fractures by 39%.  
  • Raloxifene, a selective estrogen receptor modulator (SERM), has been shown to decrease vertebral fractures by up to 50% after 3 years.  
  • Randomized controlled trials give evidence that pharmacologic therapy can reduce risk of fractures by 40 to 50%.